Alcidion Group (ALC) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
28 Oct, 2026Trading performance
FY27 contracted revenue of $50.0M as of 30 September 2026, up 38% on the prior corresponding period; new sales expected to add to the total over the remaining 8 months of FY27.
FY27 guidance reaffirmed: revenue and Underlying EBITDA expected to exceed FY26.
New and expanded contracts
Northern Care Alliance expansion: $7.5M TCV over 3 years, with options to extend up to 5 years; $4.5M expected to be recognised in FY27.
Miya will replace ExtraMed patient flow at Salford Royal and expand to additional NCA sites, with rapid implementation planned.
Health NZ MidCentral expanded to include Whanganui Hospital, extending Miya across multiple hospitals in the central region.
Product and market expansion
Miya Patient Administration launched as an AI-enabled system built on the Miya platform, using PCS experience and targeting ageing patient administration systems.
Features include referral-to-booking workflow support, validated and prioritised waiting lists, earlier visibility of bed and theatre capacity, and reduced duplicate data entry.
Canadian pipeline growing, with a dedicated business development manager planned; reseller discussions progressing in the Middle East.
Latest events from Alcidion Group
- FY26 growth and profitability support FY27 expansion, Miya PAS development and shareholder returns.ALC
AGM 2026 - Record FY26 growth, strong recurring base, and Kyra acquisition drive positive FY27 outlook.ALC
H2 2026 - Record cash flow, major contracts, and Kyra acquisition drive strong growth and outlook.ALC
Q4 2026 - H1 FY26 revenue up 44% and EBITDA up 675%, driven by major contract wins and expansions.ALC
H1 2026 - Record revenue, platform expansion, and key resolutions highlight strong FY2025 performance.ALC
AGM 2025 - Record revenue, 31% ARR growth, and major UK contracts drive strong FY26 outlook.ALC
H2 2025 - Revenue down 8%, recurring revenue 74%, cost cuts drive improved H2 EBITDA and cash flow.ALC
H2 2024 - Record cash receipts, cost savings, and major contracts drive strong FY24 performance.ALC
Q4 2024 - Record new contracts and improved EBITDA drive strong FY25 outlook and profitability.ALC
H1 2025